ARTICLE | Clinical News
Lumicef brodalumab regulatory update
July 18, 2016 7:00 AM UTC
Japan approved Lumicef brodalumab from Kyowa Hakko Kirin to treat psoriasis vulgaris, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma. A BLA for the product is under FDA review, wit...